Evidence map›Paper›PMID 29932314›Full record

ReviewESC heart failure2018

Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence.

Toshikazu D Tanaka, Mitsuaki Sawano, Ravi Ramani, Mark Friedman, Shun Kohsaka

Open access · goldAbstract readReview
In one paragraph

Review in ESC heart failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Toshikazu D TanakaDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan.ORCID 0000-0002-0711-7880
Mitsuaki SawanoDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Ravi RamaniHeart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Mark FriedmanSection of Cardiology, Sarver Heart Center, Banner University Medical Center, Tucson, AZ, USA.
Shun KohsakaDepartment of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Keio University · JPBanner - University Medical Center Tucson · USJikei University School of Medicine · JPUniversity of Pittsburgh Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, acute heart failure (AHF) remains an ongoing public health issue with its prevalence and mortality increasing in the east and the west. Effective treatment strategies to stabilize AHF are important to alleviate clinical symptoms and to improve clinical outcomes. However, despite the progress in the management of stable and chronic heart failure, no single agent has been proven to play a definitive role in the management of AHF. As a consequence, contemporary treatment strategies for patients with AHF vary greatly by region. This manuscript reviews the medical treatment options for AHF, with an emphasis on the differences between the treatment strategies in the USA and Japan. This information would provide a framework for clinicians to evaluate and manage patients with AHF and highlight the remaining questions to improve clinical outcomes.

Indexed as

Disease ManagementPractice Guidelines as TopicAcute DiseaseHeart FailureHumansJapanPrevalenceRisk FactorsUnited StatesAcute heart failureDrug therapyRegional difference

Identifiers

PMID29932314
PMCPMC6165950
OpenAlexW2809485457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.